Literature DB >> 1713108

Effect of p-chlorophenylalanine on release of 5-hydroxytryptamine from the rat frontal cortex in vivo.

M T O'Connell1, C M Portas, G S Sarna, G Curzon.   

Abstract

1. Rats were given p-chlorophenylalanine (PCPA, 150 mg kg-1, i.p.) to inhibit partially 5-hydroxytryptamine (5-HT) synthesis so that its concentration in the frontal cortex fell by about half. The effects of this treatment on frontal cortex dialysate 5-HT and 5-hydroxyindoleacetic acid (5-HIAA) concentrations were determined before and after stimulation by increasing K+ concentration in the perfusion fluid by 100 mM for 20 min. Rates of 5-HT synthesis as indicated by the effects of 3-hydroxybenzylhydrazine (NSD 1015, 150 mg kg-1, i.p.) on frontal cortex tissue and dialysate 5-hydroxytryptophan (5-HTP) and dialysate 5-HIAA were also measured in rats that had not been stimulated with K+. 2. Dialysate 5-HT and 5-HIAA concentrations of both vehicle- and PCPA-treated rats fell into major (group 1) and minor (group 2) populations statistically distinguishable from each other by the high 5-HT and low 5-HIAA values of the latter group. 3. In group 1 animals, PCPA decreased both the dialysate 5-HT concentration and its rise following stimulation by K+ in proportion with the decrease of 5-HT in frontal cortex tissue. 5-HIAA fell more markedly than 5-HT and in similar proportion in both tissue and dialysate. The fall of dialysate 5-HIAA on stimulation by K+ was also attenuated to the same degree. The elevated 5-HT/5-HIAA ratios after PCPA treatment imply increased conservation of the depleted 5-HT stores. 4. PCPA decreased the above 5-HIAA values and the effects of NSD 1015 on tissue 5-HTP or dialysate 5-HIAA concentrations in similar proportion. However, PCPA had little effect on corresponding dialysate 5-HTP values. 5. The results are discussed with respect to relationships between synthesis, storage and release of 5-HT. They indicate that (under the conditions of the present study) the availability of 5-HT to receptors is directly proportional to total vesicular stores under both basal conditions and during neuronal firing.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1713108      PMCID: PMC1917970          DOI: 10.1111/j.1476-5381.1991.tb12261.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  20 in total

1.  Simultaneous measurement of tyrosine and tryptophan hydroxylase activities in brain in vivo using an inhibitor of the aromatic amino acid decarboxylase.

Authors:  A Carlsson; J N Davis; W Kehr; M Lindqvist; C V Atack
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

2.  Tryptophan transport across the synaptosomal membrane.

Authors:  D G Grahame-Smith; A G Parfitt
Journal:  J Neurochem       Date:  1970-09       Impact factor: 5.372

3.  Attempts to measure endogenous levels of dopa and 5-hydroxytryptophan in rat brain.

Authors:  M Lindqvist; W Kehr; A Carlsson
Journal:  J Neural Transm       Date:  1975       Impact factor: 3.575

4.  Concurrent determination of effects of p-chloroamphetamine on central extracellular 5-hydroxytryptamine concentration and behaviour.

Authors:  P H Hutson; G Curzon
Journal:  Br J Pharmacol       Date:  1989-04       Impact factor: 8.739

Review 5.  Behavioral correlates of serotonin depletion.

Authors:  J A Harvey; A J Schlosberg; L M Yunger
Journal:  Fed Proc       Date:  1975-08

6.  Hippocampal Noradrenaline and Serotonin Release over 24 Hours as Measured by the Dialysis Technique in Freely Moving Rats: Correlation to Behavioural Activity State, Effect of Handling and Tail-Pinch.

Authors:  Peter Kalén; Evald Rosegren; Olle Lindvall; Anders Björklund
Journal:  Eur J Neurosci       Date:  1989-05       Impact factor: 3.386

7.  An in vivo dialysis and behavioural study of the release of 5-HT by p-chloroamphetamine in reserpine-treated rats.

Authors:  A Adell; G S Sarna; P H Hutson; G Curzon
Journal:  Br J Pharmacol       Date:  1989-05       Impact factor: 8.739

8.  5-Hydroxytryptamine: the effects of impaired synthesis on its metabolism and release in rat.

Authors:  G Curzon; J C Fernando; C A Marsden
Journal:  Br J Pharmacol       Date:  1978-08       Impact factor: 8.739

9.  Endogenous release of neuronal serotonin and 5-hydroxyindoleacetic acid in the caudate-putamen of the rat as revealed by intracerebral dialysis coupled to high-performance liquid chromatography with fluorimetric detection.

Authors:  P Kalén; R E Strecker; E Rosengren; A Björklund
Journal:  J Neurochem       Date:  1988-11       Impact factor: 5.372

10.  Serotonin release estimated by transcortical dialysis in freely-moving rats.

Authors:  E Carboni; G Di Chiara
Journal:  Neuroscience       Date:  1989       Impact factor: 3.590

View more
  6 in total

1.  Serotonergic influence on the potentiation of D-amphetamine and apomorphine-induced rotational behavior by the alpha2-adrenoceptor antagonist 2-methoxy idazoxan in hemiparkinsonian rats.

Authors:  J Srinivasan; W J Schmidt
Journal:  J Neural Transm (Vienna)       Date:  2004-12-22       Impact factor: 3.575

2.  The use of microdialysis for the study of drug kinetics: some methodological considerations illustrated with antipyrine in rat frontal cortex.

Authors:  P N Patsalos; W T Abed; M S Alavijeh; M T O'Connell
Journal:  Br J Pharmacol       Date:  1995-06       Impact factor: 8.739

3.  5,7-Dihydroxytryptamine: regional brain concentrations following intraventricular administration to rats.

Authors:  S J Choi; V Patil; J D Fernstrom
Journal:  Neurochem Res       Date:  2001-10       Impact factor: 3.996

4.  Evidence for postsynaptic mediation of the hypothermic effect of 5-HT1A receptor activation.

Authors:  M T O'Connell; G S Sarna; G Curzon
Journal:  Br J Pharmacol       Date:  1992-07       Impact factor: 8.739

5.  A microdialysis study of glycinamide, glycine and other amino acid neurotransmitters in rat frontal cortex and hippocampus after the administration of milacemide, a glycine pro-drug.

Authors:  M H Doheny; S Nagaki; P N Patsalos
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-07       Impact factor: 3.000

6.  Pharmacokinetics and pharmacodynamics of dopamine and norepinephrine in critically ill head-injured patients.

Authors:  Andrew J Johnston; Luzius A Steiner; Mark O'Connell; Dot A Chatfield; Arun K Gupta; David K Menon
Journal:  Intensive Care Med       Date:  2003-10-29       Impact factor: 17.440

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.